Literature DB >> 1513450

Central nervous system disease in patients with systemic lupus erythematosus.

N Futrell1, L R Schultz, C Millikan.   

Abstract

Central nervous system (CNS) dysfunction in patients with systemic lupus erythematosus (SLE) is highly variable, although it is often described under a single heading of "neuropsychiatric" or "CNS" SLE. To clarify these CNS abnormalities, we studied 91 lupus patients, 63 of whom had CNS symptoms or signs, over 599 patient years. By placing patients in relatively homogeneous clinical groups (stroke, seizure, suicide attempt, hallucination, confusion, decreased alertness) we detected significant (but variable among groups) correlations with other manifestations of SLE, suggesting separate mechanisms for each CNS disorder. These correlations were lost if all "CNS-SLE" was considered as a single group. Patients with decreased alertness often had undetected systemic infections and had a high death rate from infection, rather than from CNS-SLE. The understanding of the pathogenesis and potential treatment of CNS disorders in lupus will depend on classifying the patients into homogeneous groups.

Entities:  

Mesh:

Year:  1992        PMID: 1513450     DOI: 10.1212/wnl.42.9.1649

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Hemorrhagic acute disseminated encephalomyelitis as first manifestation of systemic lupus erythematosus.

Authors:  Pedro Emilio Bermejo; Angel Ruiz; Maite Beistegui; Juan Antonio Zabala; Carlos Escamilla
Journal:  J Neurol       Date:  2008-04-23       Impact factor: 4.849

2.  Very severe amnesia with acute onset after isolated hippocampal damage due to systemic lupus erythematosus.

Authors:  A Schnider; C Bassetti; A Schnider; K Gutbrod; C Ozdoba
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

Review 3.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

4.  Neuropsychological analysis in patients with systemic lupus erythematosus: a case control study.

Authors:  P J Modrego; J P Venegas; M S Cuenca; R S Moreno; A J Delgado
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

5.  Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial.

Authors:  Michelle Petri; Mohammad Naqibuddin; Margaret Sampedro; Roald Omdal; Kathryn A Carson
Journal:  Semin Arthritis Rheum       Date:  2011-04-01       Impact factor: 5.532

6.  Brainstem Reflexes in Systemic Lupus Erythematosus Patients Without Clinical Neurological Manifestations.

Authors:  Celal Salcini; Birgül Baştan; Gülin Sunter; Pınar Kahraman Koytak; Orhan Yilmaz; Tülin Tanridağ; Önder Us; Kayıhan Uluç
Journal:  Noro Psikiyatr Ars       Date:  2017-01-02       Impact factor: 1.339

7.  Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience.

Authors:  Afshin Borhani Haghighi; Shahab Ghasem Haza
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

Review 8.  Neurologic manifestations of systemic lupus erythematosus in children and adults.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

9.  Recurrent opticomyelitis associated with anti-DNA antibody.

Authors:  J Kira; I Goto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

10.  Transient life-threatening cerebral edema in a patient with systemic lupus erythematosus.

Authors:  Matt T Bianchi; Catherine Lavigne; Farzaneh Sorond; Bonnie Bermas
Journal:  J Clin Rheumatol       Date:  2009-06       Impact factor: 3.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.